Stocks TelegraphStocks Telegraph
Stock Ideas

AZTR Company Profile and Key Details

AMEX : AZTR

Azitra, Inc.

$0.31
-0.0165-5.09%
Open: 3:11 PM

AZTR Stock Price Chart

Stock Price Today

Azitra, Inc. (AZTR) stock declined over -5.09%, trading at $0.31 on AMEX, down from the previous close of $0.32. The stock opened at $0.29, fluctuating between $0.27 and $0.32 in the recent session.

Stock Snapshot

0.324
Prev. Close
0.29
Open
2.35M
Market Cap
7.63M
Number of Shares
0.27
Day Low
0.317
Day High
0
P/E Ratio
98.4%
Free Float in %
-129.41
EPS (TTM)
N/A
Book Value
N/A
Cash Flow per Share
5.76M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 04, 20250.530.590.240.32247.3M
Feb 03, 20250.250.280.240.287.42M
Jan 31, 20250.250.250.240.24868.7K
Jan 30, 20250.260.260.240.25859.6K
Jan 29, 20250.270.270.240.252.73M
Jan 28, 20250.260.350.250.3016M
Jan 27, 20250.250.260.240.251.43M
Jan 24, 20250.250.300.230.274.35M
Jan 23, 20250.250.260.240.25655.51K
Jan 22, 20250.240.270.240.273.71M
Jan 21, 20250.250.250.240.251.11M
Jan 17, 20250.270.270.240.251.75M
Jan 16, 20250.250.270.240.272.33M
Jan 15, 20250.300.300.250.265.79M
Jan 14, 20250.490.570.410.4210.55M
Jan 13, 20250.350.650.350.5832.82M
Jan 10, 20250.400.400.360.36424.94K
Jan 08, 20250.420.420.390.39453.7K
Jan 07, 20250.450.450.420.43287.42K
Jan 06, 20250.470.470.440.45351.51K

Contact Details

Branford, CT 06405

United States

Website: https://azitrainc.comContact: 203 646 6446

About Company

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Company Information

Employees10
Beta0
Sales or RevenueN/A
5Y Sales Change%9.885%
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Azitra, Inc. (AZTR) stock price?

Azitra, Inc. (AMEX: AZTR) stock price is $0.31 in the last trading session. During the trading session, AZTR stock reached the peak price of $0.32 while $0.27 was the lowest point it dropped to. The percentage change in AZTR stock occurred in the recent session was -5.09% while the dollar amount for the price change in AZTR stock was -$0.02.

AZTR's industry and sector of operation?

The AMEX listed AZTR is part of Biotechnology industry that operates in the broader Healthcare sector. Azitra, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AZTR?

No Data

How AZTR did perform over past 52-week?

AZTR's closing price is 39.06% higher than its 52-week low of $0.23 where as its distance from 52-week high of $38.10 is -99.15%.

How many employees does AZTR have?

Number of AZTR employees currently stands at 10.

Link for AZTR official website?

Official Website of AZTR is: https://azitrainc.com

How do I contact AZTR?

AZTR could be contacted at phone 203 646 6446 and can also be accessed through its website. AZTR operates from 21 Business Park Drive, Branford, CT 06405, United States.

How many shares of AZTR are traded daily?

AZTR stock volume for the day was 5.76M shares. The average number of AZTR shares traded daily for last 3 months was 1.72M.

What is the market cap of AZTR currently?

The market value of AZTR currently stands at $2.35M with its latest stock price at $0.31 and 7.63M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph